These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5401151)

  • 1. [Pathogenic and immunogenic power of Coxsackie A-10 virus propagated in tissue culture. I. Production of cytopathogenic viral strains cultivated in the presence of hydrocortisone. Determination of pathogenic and immunogenic potency in newborn and weaned mice].
    Voicoulesco C; Dincoulesco M; Epuran E
    Arch Roum Pathol Exp Microbiol; 1969 Mar; 28(1):177-88. PubMed ID: 5401151
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies of biological properties of strains of Coxsackie virus type B1 and B3].
    Taytsch FZ
    Med Dosw Mikrobiol; 1968; 20(3):299-304. PubMed ID: 5708826
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of Coxsackie A 10 virus infection in newborn and suckling mice of the strains A2G, ICR-K and CBA].
    Voiculescu C; Stanciu L; Rogoz S; Blaj-Băjeu S; Tomescu R; Tăţulescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(1):35-43. PubMed ID: 6154959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Virulence and cytologic study of Coxsackie virus effect on tissue culture cells].
    Turchin IS; Girin VM
    Mikrobiol Zh; 1967; 29(2):139-46. PubMed ID: 4979718
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary immune response to A 10 Coxsackie viral antigens in rabbit spleen cell cultures. I. In vitro synthesis of anti-A 10 Coxsackie antibodies.
    Voiculescu C; Brucher J
    Rev Roum Inframicrobiol; 1971; 8(3):195-201. PubMed ID: 5153718
    [No Abstract]   [Full Text] [Related]  

  • 6. [The physicochemical characterization of the strains isolated during the outbreak of epidemic neuropathy in Cuba. II].
    Guzman MG; Resik S; Sariol C; Rodríguez R; Alvarez M; Morier L; Castillo A; Kourí G; Más P
    Rev Cubana Med Trop; 1995; 47(1):36-40. PubMed ID: 9805065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.
    Liu CC; Lian WC; Butler M; Wu SC
    Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the adaptive properties of CoxsackieA4 viruses.
    Szalaty H
    Arch Immunol Ther Exp (Warsz); 1967; 15(6):886-90. PubMed ID: 4296807
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between neuropathogenicity of Coxsackie A 7 virus and its in vitro markers.
    Koroleva GA; Frolova MP; Voroshilova MK; Lashkevich VA
    Arch Gesamte Virusforsch; 1972; 36(3):189-204. PubMed ID: 4623185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electron microscopic studies of the nucleus of the coxsackie virus A9-infected monkey kidney cells].
    Weiss M; Meyer J; Bienz K
    Pathol Microbiol (Basel); 1970; 36(5):322-3. PubMed ID: 4998259
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells.
    Weng TY; Chen LC; Shyu HW; Chen SH; Wang JR; Yu CK; Lei HY; Yeh TM
    Antiviral Res; 2005 Jul; 67(1):31-7. PubMed ID: 15916817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the pathogenicity and immunogenicity of strains of A10 Coxsackie virus obtained by multiplication in tissue culture. II. The specific antiviral activity of the homologous and heterologous immunoglobulins IgM, IgG and IgA].
    Voïcoulesco C; Dincoulesco M; Epouran E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):629-39. PubMed ID: 5400783
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral isolation from cases of epidemic neuropathy in Cuba.
    Más P; Pelegrino JL; Guzmán MG; Comellas MM; Resik S; Alvarez M; Rodríguez R; Muné M; Capó V; Balmaseda A; Rodríguez L; Rodríguez MP; Handy J; Kourí G; Llop A
    Arch Pathol Lab Med; 1997 Aug; 121(8):825-33. PubMed ID: 9278610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of Enterovirus participation in epidemic neuropathy. Physiopathological hypothesis].
    Más Lago P; Guzmán MG; Sarmiento L; Pérez AB; Alvarez M; Capó V; Kourí G
    Rev Cubana Med Trop; 1997; 49(3):186-95. PubMed ID: 9685986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity of Coxsackie A-21 virus for suckling mice.
    Mufson MA; Kawana R; Bloom HH; Gorstein F; Chanock RM
    Proc Soc Exp Biol Med; 1968 May; 128(1):237-46. PubMed ID: 5656698
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice.
    Wu TC; Wang YF; Lee YP; Wang JR; Liu CC; Wang SM; Lei HY; Su IJ; Yu CK
    J Virol; 2007 Oct; 81(19):10310-5. PubMed ID: 17626076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interference with Coxsackie virus induced in vivo by a thermosensitive mutant].
    Gevaudan P; Charrel J; Pieroni G
    C R Seances Soc Biol Fil; 1968; 162(8):1555-6. PubMed ID: 4238180
    [No Abstract]   [Full Text] [Related]  

  • 18. [The genomic characterization of the Cuban strain with a light cytopathic effect].
    Alvarez Vera M; Sarmiento Pérez L; Guzmán Tirado MG; Beck M; Shi Q; Handy J; Más Lago P
    Rev Cubana Med Trop; 1998; 50 Suppl():267-9. PubMed ID: 10349460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coxsackie virus infection: study of 17 cases with identification of the causal agent].
    Calicó Bosch I; Jiménez Potrero M; Juvé Saumell R; Fernández Pérez F
    Med Clin (Barc); 1982 Jun; 79(1):16-21. PubMed ID: 7121103
    [No Abstract]   [Full Text] [Related]  

  • 20. [The sensitivity of struma cell cultures for the isolation of Coxsackie B viruses].
    Welke G
    Zentralbl Bakteriol Orig; 1968; 208(3):466-8. PubMed ID: 5745725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.